tetradecanoylphorbol acetate has been researched along with iguratimod in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyagi, T; Eguchi, K; Furuichi, I; Hida, A; Kawabe, Y; Kawakami, A; Matsuoka, N; Migita, K; Nakashima, M; Nakashima, T; Origuchi, T; Tsuboi, M; Urayama, S; Yamasaki, S | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and iguratimod
Article | Year |
---|---|
Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells.
Topics: Adjuvants, Immunologic; Antigen-Presenting Cells; Antigens, CD; Antirheumatic Agents; Benzopyrans; CD58 Antigens; Cell Division; Cells, Cultured; Cytokines; Depression, Chemical; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Sulfonamides; Synovial Membrane; T-Lymphocytes; Tetradecanoylphorbol Acetate; Vascular Cell Adhesion Molecule-1 | 1999 |